| Not Yet Recruiting | EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced NCT07518979 | Jiyan Liu | Phase 2 |
| Not Yet Recruiting | A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Canc NCT07497919 | Fudan University | Phase 2 |
| Recruiting | DEfeating PEnile CAncer-2 NCT07378670 | University Hospital Tuebingen | N/A |
| Recruiting | MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cel NCT07054307 | Jiyan Liu | Phase 1 |
| Not Yet Recruiting | Single-Arm Trial of QL1706, Lenvatinib, and Nab-Paclitaxel for Advanced Refractory Penile Cancer NCT07384416 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1 NCT07101822 | Hospital Israelita Albert Einstein | Phase 2 |
| Recruiting | E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972 | Christian Hinrichs | Phase 1 / Phase 2 |
| Recruiting | Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of R NCT06684327 | Fudan University | Phase 2 |
| Recruiting | Ivonescimab in the Treatment of Multiple Advanced Tumors NCT06683846 | Fudan University | Phase 2 |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Recruiting | Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer NCT06353906 | The Netherlands Cancer Institute | Phase 2 |
| Active Not Recruiting | A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese M NCT06465914 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Recruiting | TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer NCT06415318 | Sun Yat-sen University | Phase 2 |
| Recruiting | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest NCT05899361 | Dana-Farber Cancer Institute | N/A |
| Recruiting | SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas NCT06544720 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | A Chatbot Intervention for Reducing HPV Vaccine Hesitancy NCT05959564 | University of Maryland, College Park | N/A |
| Active Not Recruiting | Linking In With Advice and Supports for Men Impacted by Metastatic Cancer NCT05946993 | University College Cork | N/A |
| Suspended | Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for NCT05842031 | M.D. Anderson Cancer Center | — |
| Recruiting | Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy NCT06666634 | The Netherlands Cancer Institute | N/A |
| Recruiting | E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226 | Christian Hinrichs | Phase 2 |
| Unknown | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery NCT05739812 | The Affiliated Hospital of Qingdao University | N/A |
| Unknown | Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions NCT05662839 | The Christie NHS Foundation Trust | N/A |
| Completed | Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old NCT05518201 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 1 |
| Recruiting | The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma NCT05447273 | Oslo University Hospital | — |
| Active Not Recruiting | VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer NCT05592639 | University College, London | N/A |
| Recruiting | Lymphedema After Urologic Surgery NCT05264337 | Vastra Gotaland Region | — |
| Completed | Image Guided Penile Cancer Surgery NCT05376202 | University Medical Center Groningen | Phase 1 |
| Active Not Recruiting | A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Sm NCT04708470 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Completed | A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination NCT03856437 | University of Maryland, College Park | N/A |
| Completed | Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locati NCT04357873 | UNICANCER | Phase 2 |
| Completed | TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in NCT04475016 | Sun Yat-sen University | Phase 2 |
| Completed | Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS) NCT04231981 | MedSIR | Phase 2 |
| Completed | INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue NCT04574427 | The Netherlands Cancer Institute | — |
| Completed | Inguinal Lymphadenectomy for Penile Cancer NCT05887921 | A.O.U. Città della Salute e della Scienza | N/A |
| Unknown | Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcin NCT03774901 | Centre Hospitalier Universitaire de Besancon | Phase 2 |
| Completed | PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study NCT03686332 | The Netherlands Cancer Institute | Phase 2 |
| Active Not Recruiting | A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy NCT03391479 | University Health Network, Toronto | Phase 2 |
| Completed | Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention NCT03346915 | Boston Medical Center | N/A |
| Active Not Recruiting | Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors NCT03333616 | Dana-Farber Cancer Institute | Phase 2 |
| Unknown | Development of Diagnostics and Treatment of Urological Cancers NCT02994758 | Helsinki University Central Hospital | N/A |
| Active Not Recruiting | Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the P NCT02817958 | UNICANCER | Phase 2 |
| Completed | T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers NCT02280811 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Integrated Cancer Repository for Cancer Research NCT02012699 | University of Nebraska | — |
| Completed | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associate NCT01585428 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex NCT01209325 | AIDS Malignancy Consortium | Phase 2 |
| Terminated | Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Spari NCT00955929 | Memorial Sloan Kettering Cancer Center | N/A |
| Terminated | S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) NCT00058448 | SWOG Cancer Research Network | Phase 2 |
| Completed | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer NCT00066391 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis NCT00512096 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer NCT00019110 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer NCT00002506 | Hoag Memorial Hospital Presbyterian | Phase 2 |